// Nov 03, 2026 | Fierce Biotech
Reengineering the Economics of Autologous Cell Therapy
Katie Shannon, M.S. LinkedIn
VP, Site Head, BaseCamp Pittsburgh
Steven Binninger
Head of Emerging Technology & Business Ventures, Sartorius
Masaki Yamada
Head of Product, Invert
David Kuninger
Director, R&D Cell Biology, Thermo Fisher Scientific